Midomafetamine HCl for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 5 registered trials.

Why this status

  1. 25 May 2018: Trial registered, NCT03537014
  2. 21 Nov 2018: Trial started, NCT03537014
  3. 19 Jan 2021: Trial registered, NCT04714359
  4. 8 Mar 2021: Trial started, NCT04714359

The trials

NCT00090064: MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

State
Completed
Phase
Phase 2
People
23 taking part
Started
12 Mar 2004
Primary completion
2 May 2008
Arms
MDMA-assisted therapy (125 mg)
Results
Posted on the registry
  1. 25 Aug 2004: Trial registered
  2. 21 Jun 2010: Trial completed
  3. 25 Oct 2021: Trial results posted

NCT01958593: Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD

State
Stopped early
Phase
Phase 2
People
6 taking part
Started
14 Oct 2014
Primary completion
10 Sep 2015
Arms
MDMA-assisted therapy
Results
Posted on the registry
  1. 9 Oct 2013: Trial registered
  2. 14 Oct 2014: Trial started
  3. 17 Oct 2016: Trial terminated
  4. 2 Aug 2021: Trial results posted

NCT03537014: A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

State
Completed
Phase
Phase 3
People
100 taking part
Started
21 Nov 2018
Primary completion
11 Aug 2020
Arms
MDMA-assisted therapy
Results
Posted on the registry
  1. 25 May 2018: Trial registered
  2. 21 Nov 2018: Trial started
  3. 21 Aug 2020: Trial completed
  4. 16 Sep 2021: Trial results posted

NCT04030169: Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study

State
Completed
Phase
Phase 2
People
21 taking part
Started
24 Jun 2020
Primary completion
14 Dec 2023
Arms
Experimental: MDMA-assisted psychotherapy
Results
Posted on the registry
  1. 23 Jul 2019: Trial registered
  2. 24 Jun 2020: Trial started
  3. 15 Dec 2023: Trial completed
  4. 28 Jan 2025: Trial results posted

NCT04714359: A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD

State
Completed
Phase
Phase 3
People
87 taking part
Started
8 Mar 2021
Primary completion
1 Nov 2023
Arms
MDMA-assisted therapy
Results
Posted on the registry
  1. 19 Jan 2021: Trial registered
  2. 8 Mar 2021: Trial started
  3. 6 Nov 2023: Trial completed
  4. 29 Nov 2024: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.